tradingkey.logo

Progyny Inc

PGNY
21.950USD
+0.030+0.14%
Close 02/06, 16:00ETQuotes delayed by 15 min
1.89BMarket Cap
33.63P/E TTM

Progyny Inc

21.950
+0.030+0.14%

More Details of Progyny Inc Company

Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.

Progyny Inc Info

Ticker SymbolPGNY
Company nameProgyny Inc
IPO dateOct 25, 2019
CEOAnevski (Peter)
Number of employees675
Security typeOrdinary Share
Fiscal year-endOct 25
Address1359 Broadway
CityNEW YORK
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code10018
Phone12128883124
Websitehttps://www.progyny.com/
Ticker SymbolPGNY
IPO dateOct 25, 2019
CEOAnevski (Peter)

Company Executives of Progyny Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Peter (Pete) Anevski
Mr. Peter (Pete) Anevski
Chief Executive Officer, Director
Chief Executive Officer, Director
375.10K
-6009.00%
Ms. Melissa Cummings
Ms. Melissa Cummings
Chief Operating Officer
Chief Operating Officer
41.67K
+41667.00%
Mr. Jeffrey Gary (Jeff) Park
Mr. Jeffrey Gary (Jeff) Park
Lead Independent Director
Lead Independent Director
32.06K
+9364.00%
Mr. Geoffrey Clapp
Mr. Geoffrey Clapp
Chief Product Officer
Chief Product Officer
28.69K
+28694.00%
Mr. Kevin K. Gordon
Mr. Kevin K. Gordon
Independent Director
Independent Director
23.03K
+8026.00%
Mr. Roger C. Holstein
Mr. Roger C. Holstein
Independent Director
Independent Director
21.94K
+8026.00%
Mr. Lloyd H. Dean
Mr. Lloyd H. Dean
Independent Director
Independent Director
19.73K
+8026.00%
Ms. Cheryl M. Scott
Ms. Cheryl M. Scott
Independent Director
Independent Director
14.11K
-2675.00%
Ms. Allison Swartz
Ms. Allison Swartz
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
12.49K
-938.00%
Mr. Mark S. Livingston
Mr. Mark S. Livingston
Chief Financial Officer
Chief Financial Officer
9.18K
-2511.00%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Peter (Pete) Anevski
Mr. Peter (Pete) Anevski
Chief Executive Officer, Director
Chief Executive Officer, Director
375.10K
-6009.00%
Ms. Melissa Cummings
Ms. Melissa Cummings
Chief Operating Officer
Chief Operating Officer
41.67K
+41667.00%
Mr. Jeffrey Gary (Jeff) Park
Mr. Jeffrey Gary (Jeff) Park
Lead Independent Director
Lead Independent Director
32.06K
+9364.00%
Mr. Geoffrey Clapp
Mr. Geoffrey Clapp
Chief Product Officer
Chief Product Officer
28.69K
+28694.00%
Mr. Kevin K. Gordon
Mr. Kevin K. Gordon
Independent Director
Independent Director
23.03K
+8026.00%
Mr. Roger C. Holstein
Mr. Roger C. Holstein
Independent Director
Independent Director
21.94K
+8026.00%

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Fertility benefits services revenue
201.95M
64.45%
Pharmacy benefits services revenue
111.40M
35.55%
By RegionUSD
Name
Revenue
Proportion
United States
313.35M
100.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Fertility benefits services revenue
201.95M
64.45%
Pharmacy benefits services revenue
111.40M
35.55%

Shareholding Stats

Updated: Sat, Feb 7
Updated: Sat, Feb 7
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.63%
The Vanguard Group, Inc.
11.15%
Seidenberg (Beth C)
6.20%
Kleiner, Perkins, Caufield & Byers
5.89%
Fidelity Management & Research Company LLC
5.22%
Other
57.91%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.63%
The Vanguard Group, Inc.
11.15%
Seidenberg (Beth C)
6.20%
Kleiner, Perkins, Caufield & Byers
5.89%
Fidelity Management & Research Company LLC
5.22%
Other
57.91%
Shareholder Types
Shareholders
Proportion
Investment Advisor
55.16%
Investment Advisor/Hedge Fund
30.29%
Individual Investor
7.66%
Hedge Fund
6.46%
Venture Capital
6.00%
Research Firm
3.89%
Pension Fund
1.80%
Bank and Trust
0.53%
Sovereign Wealth Fund
0.12%

Institutional Shareholding

Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
763
90.10M
104.51%
-29.84M
2025Q3
749
88.02M
102.17%
-28.58M
2025Q2
750
92.53M
107.94%
-27.39M
2025Q1
761
91.24M
106.44%
-29.72M
2024Q4
736
97.21M
113.81%
-18.60M
2024Q3
721
97.59M
108.87%
-13.76M
2024Q2
700
102.42M
113.70%
-10.92M
2024Q1
684
101.40M
106.22%
-3.55M
2023Q4
667
98.10M
102.55%
-7.56M
2023Q3
653
97.93M
102.95%
-1.75M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
11.75M
13.63%
+473.32K
+4.20%
Sep 30, 2025
The Vanguard Group, Inc.
10.09M
11.7%
+231.92K
+2.35%
Sep 30, 2025
Seidenberg (Beth C)
5.35M
6.2%
+7.21K
+0.13%
May 23, 2024
Kleiner, Perkins, Caufield & Byers
5.07M
5.89%
--
--
Mar 28, 2025
Fidelity Management & Research Company LLC
4.50M
5.22%
+1.27M
+39.38%
Sep 30, 2025
State Street Investment Management (US)
2.91M
3.37%
+41.05K
+1.43%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.95M
2.26%
+207.58K
+11.90%
Sep 30, 2025
ArrowMark Colorado Holdings, LLC
1.93M
2.24%
+39.67K
+2.10%
Sep 30, 2025
Thrivent Asset Management, LLC
2.16M
2.5%
-2.73M
-55.86%
Sep 30, 2025
Fort Washington Investment Advisors, Inc.
1.66M
1.92%
+412.39K
+33.15%
Sep 30, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Alger Weatherbie Enduring Growth ETF
3.51%
State Street SPDR S&P Health Care Services ETF
1.69%
Invesco S&P SmallCap 600 GARP ETF
1.52%
First Trust Small Cap US Equity Select ETF
1%
Invesco S&P SmallCap Health Care ETF
0.92%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.83%
First Trust Active Factor Small Cap ETF
0.64%
VictoryShares Small Cap Free Cash Flow ETF
0.56%
First Trust Small Cap Growth AlphaDEX Fund
0.52%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.49%
View more
Alger Weatherbie Enduring Growth ETF
Proportion3.51%
State Street SPDR S&P Health Care Services ETF
Proportion1.69%
Invesco S&P SmallCap 600 GARP ETF
Proportion1.52%
First Trust Small Cap US Equity Select ETF
Proportion1%
Invesco S&P SmallCap Health Care ETF
Proportion0.92%
Pacer US Small Cap Cash Cows Growth Leaders ETF
Proportion0.83%
First Trust Active Factor Small Cap ETF
Proportion0.64%
VictoryShares Small Cap Free Cash Flow ETF
Proportion0.56%
First Trust Small Cap Growth AlphaDEX Fund
Proportion0.52%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion0.49%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI